CLDX
#1686
Celldex Therapeutics, Inc. - Common Stock
40.4 6 USD
0.00%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-0.27%
Monthly Change
+13.72%
6 month change
+35.14%
Year Change
+48.53%
Previous Close
40.5 7
Open
40.4 6
Low
40.4 6
High
40.4 6
Volume
62
Financials
- Market Capitalization 3.18 B
- Employee 198
- Founded 1983
- CEO N/A
- Website www.celldex.com
- Headquarter Delaware, United States
- FIGI BBG000FW8LZ9
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-6.96
Price to sales ratio
1 167.65
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1668 |  IMNM Immunome, Inc. - Common Stock | 28.87 USD | +0.42% | +1.44% | +24.01% | +191.91% | 3.28 B USD | ||
| 1681 |  NAMS NewAmsterdam Pharma Company N.V. - Ordinary Shares | 26.79 USD | -2.23% | -4.29% | -5.17% | -26.14% | 3.20 B USD | ||
| 1688 |  IRON Disc Medicine, Inc. - Common Stock | 82.55 USD | -0.15% | +3.84% | +10.86% | +37.93% | 3.17 B USD | ||
| 1694 |  TARS Tarsus Pharmaceuticals, Inc. - Common Stock | 71.92 USD | +1.80% | +0.28% | +22.40% | +8.87% | 3.16 B USD |
Frequently asked questions about Celldex Therapeutics, Inc
What is the Celldex Therapeutics, Inc stock price today?
The current price of Celldex Therapeutics, Inc (CLDX) is 40.46. Over the past 24 hours, the stock has changed by -0.27%. Follow the CLDX chart for real-time price dynamics.
What is the stock ticker of Celldex Therapeutics, Inc?
Celldex Therapeutics, Inc trades under the ticker CLDX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Celldex Therapeutics, Inc stock going up?
CLDX has changed by +0.20% over the last week, +13.72% over the last month, and +48.53% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Celldex Therapeutics, Inc?
Celldex Therapeutics, Inc currently has a market capitalization of 3.18 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Celldex Therapeutics, Inc earnings last quarter?
Last quarter, Celldex Therapeutics, Inc reported earnings of -0.94 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Celldex Therapeutics, Inc revenue for the last quarter?
Celldex Therapeutics, Inc reported quarterly revenue of 22 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Celldex Therapeutics, Inc net income for the last quarter?
Celldex Therapeutics, Inc reported net income of -73.5 M for the last quarter. The previous quarter showed -78.69 M, which means net income changed by +6.59%.
How many employees does Celldex Therapeutics, Inc have?
As of the latest available data, Celldex Therapeutics, Inc has 198 employees. Workforce size can provide additional context about the company's scale and operations.
What is Celldex Therapeutics, Inc EBITDA?
Celldex Therapeutics, Inc EBITDA is -79.72 M, and its EBITDA margin is -362.37 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Celldex Therapeutics, Inc stock?
You can buy Celldex Therapeutics, Inc (CLDX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Celldex Therapeutics, Inc stock?
Investing in Celldex Therapeutics, Inc requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CLDX chart and related analysis on metatrader.com as part of your research.